NCT01024140View on ClinicalTrials.gov

Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Chronic Posttraumatic Stress Disorder
Interventions
DRUG

Escitalopram

Subjects were started on 5mg escitalopram. Medication was increased as tolerated in weekly 2.5, 5 or 10 mg increments, until a maximally tolerated dosage or a clinical response was achieved. The final dosage ranged from 5 to 20 mg/day.

All Listed Sponsors
lead

Northern California Institute of Research and Education

OTHER

NCT01024140 - Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder | Biotech Hunter | Biotech Hunter